| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |